Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?

被引:10
作者
Dequanter, Didier
Lothaire, Philippe
Awada, Ahmad
Lalami, Yassine
Nguyen, Thi Hien
Lemort, Marc
Vandevelde, Luc
Andry, Guy
机构
[1] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Dept Surg, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Med Oncol Clin, B-1000 Brussels, Belgium
[3] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Dept Radiotherapy, B-1000 Brussels, Belgium
[4] Univ Libre Bruxelles, Ctr Tumeurs, Inst Jules Bordet, Dept Radiol, B-1000 Brussels, Belgium
关键词
head and neck cancer; N2-N3 neck disease; clinical response; radiological response; chemoradiotherapy; neck dissection;
D O I
10.1080/00016480600818088
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Conclusion: A complete clinical and radiological response observed following chemotherapy and radiotherapy is not predictive of the absence of residual disease. Moreover, salvage neck surgery does not always seem to be an effective strategy. Consequently, early neck dissection should be advised for patients with complete clinical and radiological response (CCRR) after chemoradiotherapy for tumors with N2 - N3 disease. Background: We retrospectively reviewed the outcome of 28 patients with N2 - N3 disease treated initially with chemotherapy and radiotherapy. Patients and methods: A neck dissection was performed for all patients with residual disease in the neck. Results: A CCRR in the neck was achieved in 25 of 28 patients. The remaining three patients with residual neck mass underwent a salvage neck dissection: the pathological examination confirmed the persistence of tumoral disease. No regional failure was observed in these three patients. In 25 patients considered to have CCRR in the neck, 5 patients (20%) developed regional recurrence. Successful salvage approach was not possible for any of these patients.
引用
收藏
页码:1225 / 1228
页数:4
相关论文
共 14 条
[1]   Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome [J].
Ampil, FL ;
Mills, GM ;
Caldito, G ;
Burton, GV ;
Nathan, CAO ;
Aarstad, RF ;
Lian, TF ;
Stucker, FJ ;
Hardin, JC .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 126 (06) :602-606
[2]   Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer [J].
Argiris, A ;
Stenson, KM ;
Brockstein, BE ;
Mittal, BB ;
Pelzer, H ;
Kies, MS ;
Jayaram, P ;
Portugal, L ;
Wenig, BL ;
Rosen, FR ;
Haraf, DJ ;
Vokes, EE .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (05) :447-455
[3]   Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer [J].
Brizel, DM ;
Prosnitz, RG ;
Hunter, S ;
Fisher, SR ;
Clough, RL ;
Downey, MA ;
Scher, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05) :1418-1423
[4]   Neck dissection following radiochemotherapy of advanced head and neck cancer -: for selected cases only? [J].
Grabenbauer, GG ;
Rödel, C ;
Ernst-Stecken, A ;
Brunner, T ;
Hornung, J ;
Kittel, K ;
Steinhart, H ;
Iro, H ;
Sauer, R ;
Schultze-Mosgau, S .
RADIOTHERAPY AND ONCOLOGY, 2003, 66 (01) :57-63
[5]  
Johnson C R, 1998, Radiat Oncol Investig, V6, P52, DOI 10.1002/(SICI)1520-6823(1998)6:1<52::AID-ROI6>3.0.CO
[6]  
2-H
[7]   Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer [J].
Lavertu, P ;
Bonafede, JP ;
Adelstein, DJ ;
Saxton, JP ;
Strome, M ;
Wanamaker, JR ;
Eliachar, I ;
Wood, BG .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1998, 124 (04) :401-406
[8]   Treatment of neck nodes after induction chemotherapy in patients with primary advanced tumours [J].
Leon, X ;
Quer, M ;
Orus, C ;
de Dios, E ;
Recher, K .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2000, 257 (09) :521-525
[9]   Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? [J].
McHam, SA ;
Adelstein, DJ ;
Rybicki, LA ;
Lavertu, P ;
Esclamado, RM ;
Wood, BG ;
Strome, M ;
Carroll, MA .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (10) :791-798
[10]   Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer [J].
Newman, JP ;
Terris, DJ ;
Pinto, HA ;
Fee, WE ;
Goode, RL ;
Goffinet, DR .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (02) :117-122